Navigation Links
Prozac Makes Old Brain Cells Young
Date:4/17/2008

Research may explain antidepressants' effectiveness

THURSDAY, April 17 (HealthDay News) -- The antidepressant Prozac has been shown to restore old brain cells to their more plastic youthful condition in animal experiments, researchers report.

The work not only provides a possible new explanation for the antidepressant activity of the medication but also raises the distant prospect that it could be used to treat other conditions caused by malfunction of brain cells, said study lead author Jose Fernando Maya Vetencourt.

"It suggests potential clinical applications for the drug in different pathologies," said Vetencourt, a researcher in neurobiology at the Scuola Normale Superiore in Pisa, Italy. One of them is amblyopia, the "lazy eye" condition in which one eye is weaker than the other, because it was not used enough in early childhood, he said.

It's much too early to say when, whether or how Prozac, whose generic name is fluoxetine, could be used in such treatments, Vetencourt said. It's also too early to say whether other members of the chemical family of antidepressants to which Prozac belongs have the same youth-restoring ability, or whether other antidepressants do the same thing, he said.

"All this needs to be validated in animal models," Vetencourt said. His study colleagues, who included researchers in Finland, have begun to study "the expression of genes which may be correlated to the functional changes," he said.

The findings were published in the April 17 issue of the journal Science.

Amblyopia was listed as a possible target, because the experiments were aimed at the brain cells governing vision. Vetencourt and his colleagues gave regular doses of Prozac to adult rats whose vision had been impaired by lack of exposure to visual images at a critical period in their early development. Tests showed changes in brain protein expression and electrical signaling typical of younger brain cells and recovery of vision by the animals.

Future experiments will try to determine whether the same treatment will have a similar effect on brain cells governing functions other than vision, Vetencourt said.

Prozac is one of the antidepressant drugs listed as selective serotonin reuptake inhibitors (SSRIs), so called because they block the activity of serotonin, a molecule that transmits signals between brain cells. There are a number of other chemical families of antidepressant drugs, also described by their activity affecting brain chemistry -- MAO inhibitors, for example.

"There have been discussions about the theory that a cause of depression is lack of growth in the brain," said Dr. Julio Licinio, chairman of psychiatry at the University of Miami Miller School of Medicine. "It used to be thought that no change could occur in the adult brain. New research has shown that there can be new growth in the brain, so the theory is that depression is caused by lack of new growth."

The new study "supports that theory in a very interesting way," Licinio said. "It both shows a potential new treatment for depression and also further supports the idea that antidepressants act because they promote growth in the brain."

And what applies to Prozac probably is true of other SSRIs and of antidepressants in general, he said. "There have been a lot of other papers showing that other antidepressants have the same property of growth in the brain," Licinio said.

More information

You can learn more about antidepressants from the U.S. National Library of Medicine.



SOURCES: Jose Fernando Maya Vetencourt, Ph.D., researcher, neurobiology, Scuola Normale Superiore, Pisa, Italy; Julio Licinio, M.D., chairman, psychiatry, Unversity of Miami Miller School of Medicine; April 18, 2008, Science


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Smart Technology Makes Patient Data Collection Easier, More Efficient
2. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
3. Independence Blue Cross Makes Music for Members Ears
4. A Place for Mom COO Makes Seattles 40 Under 40 List
5. Sesame Street Exhibition Makes Texas Premier at The Health Museum
6. Study makes progress in zoning in on biomarkers for better colon cancer treatment
7. New Online Tool Makes Enrollment in Blue Cross of California Easier
8. 1-800-PACK-RAT Makes a Splash During Annual Walk for Hope
9. Eye on Safety Makes Halloween Less Scary
10. An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal
11. Michigan State Medical Society Foundation Makes A Difference by Assisting Those in Crisis Shelters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... muscle mass and overall body strength, which often leads to a host of ... Journal of the American Geriatrics Society discovered that good overall muscle ...
(Date:2/27/2017)... ... 27, 2017 , ... Much attention has been paid to the problem of ... opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription pain ... overdoses in male populations.(1) , The proportion of women using illicit drugs is also ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... on laser diffraction analysis as a tool to characterize particle size distributions in ... to obtain improved results and novel scientific findings. It describes methods of optimized ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/26/2017)... ... ... The February 13, 2017, assassination of Kim Jong-nam, the half brother of ... deadly use of chemical weapons. Many questions exist about the effect that nerve agents ... lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and one of the ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... -- International Biophysics Corporation, a global medical device manufacturer based in ... revenue growth in 2016 when compared to the previous year ... was fueled by its AffloVest® sales in the ... its global sales of surgical product lines. Said ... our 25 th year in delivering high-quality, innovative medical ...
(Date:2/27/2017)... Calif. , Feb. 27, 2017   Vitasome ... line of nutritional supplements using its groundbreaking new liposome ... 90 percent of potency through digestion per Physician,s ... supplements solve the problem of nutritional waste and are ... degradation during digestive processes Improve bioavailability ...
(Date:2/27/2017)... Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... development company focused on tissue protection, repair and ... GtreeBNT Co., Ltd., received a positive response from ... trial design for RGN-137 to treat epidermolysis bullosa ... that incorporates Thymosin beta 4 ("Tß4") as the ...
Breaking Medicine Technology: